ABVC BioPharma Stock Forecast, Price & News

+0.54 (+12.27 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume571 shs
Average Volume719 shs
Market Capitalization$131.85 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ABVC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter.

About ABVC BioPharma

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.05 out of 5 stars

Medical Sector

1262nd out of 2,222 stocks

Pharmaceutical Preparations Industry

588th out of 869 stocks

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

ABVC BioPharma (OTCMKTS:ABVC) Frequently Asked Questions

What stocks does MarketBeat like better than ABVC BioPharma?

Wall Street analysts have given ABVC BioPharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ABVC BioPharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ABVC BioPharma's stock price been impacted by Coronavirus (COVID-19)?

ABVC BioPharma's stock was trading at $2.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABVC stock has increased by 70.3% and is now trading at $4.94.
View which stocks have been most impacted by COVID-19

Who are ABVC BioPharma's key executives?

ABVC BioPharma's management team includes the following people:
  • Mr. Eugene Jiang, Chairman & Chief Bus. Officer (Age 35, Pay $200k)
  • Dr. Howard Doong M.D., Ph.D., Pres & CEO (Age 64, Pay $200k)
  • Mr. Chihliang An, Chief Financial Officer (Age 39, Pay $200k)
  • Dr. Chi-Hsin King, Chief Scientific Officer (Age 73, Pay $200k)
  • Dr. Tsung-Shann Jiang Ph.D., Chief Strategy Officer, Member of Scientific Advisory Board & Director (Age 67, Pay $200k)

Who are some of ABVC BioPharma's key competitors?

What is ABVC BioPharma's stock symbol?

ABVC BioPharma trades on the OTCMKTS under the ticker symbol "ABVC."

How do I buy shares of ABVC BioPharma?

Shares of ABVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ABVC BioPharma's stock price today?

One share of ABVC stock can currently be purchased for approximately $4.94.

How much money does ABVC BioPharma make?

ABVC BioPharma has a market capitalization of $131.85 million and generates $480,000.00 in revenue each year.

How many employees does ABVC BioPharma have?

ABVC BioPharma employs 30 workers across the globe.

What is ABVC BioPharma's official website?

The official website for ABVC BioPharma is www.ambrivis.com.

Where are ABVC BioPharma's headquarters?

ABVC BioPharma is headquartered at 44370 Old Warm Springs Blvd, Fremont CA, 94538.

How can I contact ABVC BioPharma?

ABVC BioPharma's mailing address is 44370 Old Warm Springs Blvd, Fremont CA, 94538. The company can be reached via phone at 845-291-1291.

This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.